Sunday, 30 November 2014

Hurdles facing medical cannabis in Germany

Depending on the indication, it is moderately difficult to obtain prepared cannabis drugs on prescription. When it comes to the plant version it becomes complex but not irresolvable. Germany must supply patients with cannabis whether it wants to or not because some patients have gone to court to obtain it.

 http://www.tokeofthetown.com/2012/12/27/germany.img_assist_custom-250x159.jpeg
Import is expensive because transport to and sale in Germany costs between 9 and 14 euros per gram – ultimately more than the flower itself. The German government has for years been refusing to allow the medicine to be produced domestically because it does not want to establish a cannabis agency. After all, a cannabis agency would mean regulation, and most importantly the standardisation of natural cannabis medication.

In Germany, the country with the most powerful pharmaceutics lobby in the EU, this is not politically desirable. This is why the import model and bureaucratic monster known as the “Certificate of exemption under § 3 clause 2 of the Narcotics Act” was established. It is a way of protecting against lawsuits from more patients and at the same time creating enormous hurdles which many ill people cannot get over on their own. For the moment, at least.

Continue reading: http://sensiseeds.com/en/blog/hurdles-facing-natural-cannabis-medicine/?utm_source=rss&utm_medium=rss&utm_campaign=hurdles-facing-natural-cannabis-medicine

No comments:

Post a Comment